JPMorgan Chase & Co. Issues Pessimistic Forecast for Afya (NASDAQ:AFYA) Stock Price

Afya (NASDAQ:AFYA) had its target price lowered by JPMorgan Chase & Co. from $25.00 to $20.50 in a research note published on Friday morning,Benzinga reports. The firm currently has a neutral rating on the stock.

Separately, The Goldman Sachs Group began coverage on Afya in a report on Tuesday, December 3rd. They issued a “sell” rating and a $16.00 target price on the stock. One investment analyst has rated the stock with a sell rating and four have assigned a hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $19.60.

Afya Stock Performance

Shares of Afya stock opened at $15.74 on Friday. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 0.51. The company has a market cap of $1.48 billion, a PE ratio of 12.69, a price-to-earnings-growth ratio of 0.25 and a beta of 0.89. The company has a 50 day moving average of $15.96 and a 200-day moving average of $16.75. Afya has a 1-year low of $14.52 and a 1-year high of $22.48.

Hedge Funds Weigh In On Afya

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Renaissance Technologies LLC grew its stake in shares of Afya by 19.7% during the second quarter. Renaissance Technologies LLC now owns 266,500 shares of the company’s stock worth $4,704,000 after buying an additional 43,800 shares during the last quarter. Marshall Wace LLP boosted its holdings in shares of Afya by 41.8% during the 2nd quarter. Marshall Wace LLP now owns 336,985 shares of the company’s stock valued at $5,948,000 after acquiring an additional 99,416 shares in the last quarter. Cubist Systematic Strategies LLC grew its position in Afya by 136.9% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 35,254 shares of the company’s stock worth $622,000 after acquiring an additional 20,370 shares during the last quarter. Millennium Management LLC increased its holdings in Afya by 45.0% in the 2nd quarter. Millennium Management LLC now owns 291,164 shares of the company’s stock worth $5,139,000 after purchasing an additional 90,383 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale bought a new position in Afya in the third quarter valued at about $417,000. Institutional investors own 88.02% of the company’s stock.

About Afya

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.